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Neuropeptides are ancient regulators of physiology and behaviour, but reconstruc-
tion of neuropeptide evolution is often difficult owing to lack of sequence
conservation. Here, we report that the receptor for the neuropeptide NGFFFamide
in the sea urchin Strongylocentrotus purpuratus (phylum Echinodermata) is an
orthologue of vertebrate neuropeptide-S (NPS) receptors and crustacean
cardioactive peptide (CCAP) receptors. Importantly, this has facilitated reconstruc-
tion of the evolution of two bilaterian neuropeptide signalling systems. Genes
encoding the precursor of a vasopressin/oxytocin-type neuropeptide and its
receptor duplicated in a common ancestor of the Bilateria. One copy of the precur-
sor retained ancestral features, as seen in highly conserved vasopressin/oxytocin–
neurophysin-type precursors. The other copy diverged, but this took different
courses in protostomes and deuterostomes. In protostomes, the occurrence of a
disulfide bridge in neuropeptide product(s) of the precursor was retained, as in
CCAP, but with loss of the neurophysin domain. In deuterostomes, we see the
opposite scenario—the neuropeptides lost the disulfide bridge, and neurophysin
was retained (as in the NGFFFamide precursor) but was subsequently lost in
vertebrate NPS precursors. Thus, the sea urchin NGFFFamide precursor and
receptor are ‘missing links’ in the evolutionary history of neuropeptides that
control ecdysis in arthropods (CCAP) and regulate anxiety in humans (NPS).2. Introduction
Sequencing of the human genome revealed the presence of many genes encod-
ing G-protein coupled neuropeptide receptors (GPCRs) with unknown
ligands—so-called orphan receptors [1]—and one of the first to be ‘deorpha-
nized’ was GPR154. Comparison of the sequence of GPR154 with other
GPCRs in humans revealed that it is most closely related to vasopressin/oxyto-
cin (VP/OT)-type receptors, and therefore it was also referred to as vasopressin
receptor-related receptor 1 (VRR1). However, when the pharmacological prop-
erties of VRR1/GPR154 were analysed it was found that VP/OT-type peptides
are not ligands for this receptor [2]. Therefore, efforts were made to purify the
endogenous ligand for this receptor from brain extracts, and it was found to be
a 20-residue peptide with the sequence SFRNGVGTGMKKTSFQRAKS, which
was named neuropeptide-S (NPS) on account of the N-terminal serine residue
[3]. Interestingly, however, NPS does not share structural similarity with VP/
OT-type peptides. Analysis of the physiological roles of NPS in rodents has
revealed that it has an anxiolytic-like action, while also causing arousal [3]. Sub-
sequently, it has been found that polymorphisms in the NPS receptor (NPSR)
are associated with panic disorders in humans [4,5]. Thus, these findings
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humans and other mammals.
Investigation of the phylogenetic distribution of NPS
and NPSR has revealed that genes encoding these proteins are
present in tetrapod vertebrates but not in teleost fish or other
non-tetrapod vertebrates, which suggested that the NPS–
NPSR signalling system may have originated in a common
ancestor of tetrapods [6]. However, a broader phylogenetic
analysis reveals that orthologues of NPSR are not only present
in tetrapod vertebrates, but are also found in invertebrates; for
example, NPSR-related proteins are present in Drosophila and
other insects [7,8]. Furthermore, the ligand that activates the
NPSR-type protein in Drosophila has been identified as crus-
tacean cardioactive peptide, or CCAP (PFCNAFTGCamide), a
neuropeptide that controls ecdysis behaviour in insects [9–11].
Interestingly, NPS and CCAP share very little sequence simi-
larity, and therefore the discovery that their receptors are
orthologous was unexpected.
When CCAP was originally identified on account of its
excitatory effect on crab hearts, it was noted that it shares super-
ficial sequence similarity with VP/OT-type neuropeptides—in
particular, the presence of a disulfide bridge between two
cysteine residues [12]. CCAP precursor proteins do not, how-
ever, have a neurophysin domain, which is a characteristic
feature of VP/OT-type precursors [13]. Nevertheless, the fact
that CCAP receptors are paralogous to VP/OT-type receptors
[8] suggests that CCAP and VP/OT-type peptides may have
evolved from a common ancestral molecule. What is not clear,
however, is the relationship between NPS and VP/OT-type
peptides or CCAP. NPS shares no apparent structural similarity
with VP/OT-type peptides, although it has been reported that
NPS shares an FxN motif with CCAP [7,8].
A strategy to bridge understanding of relationships
between neuropeptides in vertebrates (e.g. NPS) and neuropep-
tides in distantly related protostomian invertebrates such as
insects (e.g. CCAP) is to analyse neuropeptide systems in
deuterostomian invertebrates (e.g. cephalochordates, hemi-
chordates, echinoderms), which are more closely related to
vertebrates than protostomian invertebrates [14]. Analysis of
genome sequence data has revealed thatNPSR/CCAPR-related
proteins are present in deuterostomian invertebrates [8,15].
Furthermore,we have discovered a gene in the cephalochordate
Branchiostoma floridae that encodes a neuropeptide-type pre-
cursor protein containing two copies of an NPS-like peptide
with the predicted amino acid sequence SFRNGVamide [16].
This peptide is identical to the bioactive N-terminal region
of NPS [17], indicating that SFRNGVamide and NPS may
have a common evolutionary origin. Homologues of the
SFRNGVamide precursor are also present in non-chordate
deuterostomian invertebrates—for example, the hemichordate
Saccoglossus kowalevskii (acorn worm) and the echinoderm
Strongylocentrotus purpuratus (sea urchin). The neuropeptides
derived from these precursors have in common with SFRNGV-
amide (and NPS) the structural motif Asn–Gly (NG)—the
S. kowalevskii precursor contains five copies of NGFWNamide
and one copy of NGFYNamide, and the S. purpuratus precursor
contains two copies of the putative neuropeptide NGFFFamide.
Therefore, this family of neuropeptides in deuterostomian
invertebrates has been designated as ‘NG peptides’ [16].
A surprising feature of NG peptide precursors in deu-
terostomian invertebrates is that they contain a neurophysin
domain. Hitherto, neurophysins were thought to be a unique
feature of VP/OT-type precursors, where they are required foraxonal transport and secretion of neuropeptides [18]. Therefore,
the discovery that NG peptides in deuterostomian invertebrates
are derived from neurophysin-containing precursors changed
the textbook perspective on neurophysins [16]. Furthermore,
the presence of a neurophysin domain inNGpeptide precursors
provides a ‘missing link’ between NPS and VP/OT-type pep-
tides. It suggests that an ancestral VP/OT-type precursor gene
duplicated and one copy retained the highly conserved features
of VP/OT-type precursors, whereas the other copy gave rise, on
the one hand, to genes encoding NG peptide precursors in deu-
terostomian invertebrates, and on the other hand, to genes
encoding CCAP-type neuropeptides in protostomian invert-
ebrates. To address this hypothesis, the principal objective of
the study presented here was to determine whether an NPSR-
related receptor in a deuterostomian invertebrate species, the
sea urchin S. purpuratus, is activated by NG peptides.3. Material and methods
3.1. Mass spectrometry
Extracts of adult S. purpuratuswere prepared byDrRobert Burke
at theUniversity of Victoria (British Columbia, Canada). The test
and viscera were homogenized separately in a Waring blender
and then centrifuged (15 000g for 10 min). The supernatant
was lyophilizedovernight, andstoredat2808Cprior to shipping
toQMUL (UK). Peptideswere extracted using an alcohol solvent
(a 90 : 9 : 1 ratio ofmethanol : water : acetic acid), using an extrac-
tion protocol adapted fromHusson et al. [19]. After removing the
methanol solventbyevaporation, theextractwasdelipidated in a
1 : 1 ratio solution of ethyl acetate and n-hexane. Extractswere fil-
tered using a C18 Sep-Pak cartridge (Waters), with solutions
applied to the C18 column prepared in 0.1% formic acid. The
column was washed with 40% acetonitrile, before loading 5 ml
of extract, slowly washing with water, then 30% acetonitrile to
remove pigment, before elution of the peptides with 80%
acetonitrile, which was then removed by evaporation.
The HPLC–MS system used for peptide detection incor-
porated an Agilent 1100 Series pumping system, a Vydac C8
chromatography column (cat. no. 208TP54), an atmospheric
pressure interface electrospray source, an ion trap mass analy-
ser and a dynode-based system for ion detection. The nebulizer
pressurewas set to 40 psi, the flow ratewas set to 0.5 ml min21
and the injection volume set to 20 ml. Synthetic NGFFFamide
(synthesized by the Advanced Biotechnology Centre, Imperial
College London)was used as a standard for the optimization of
mass spectrometry parameters. Synthetic NGFFFamide was
found to elute at a concentration of 39–47% acetonitrile, at
three different increasing flow rate gradients from 0.5% to 2%
acetonitrile per minute. Thus, the detection of NGFFFamide
in extracts of sea urchin tissue was guided by the elution
point of the synthetic peptide run on an identical gradient.
3.2. Cloning of a cDNA encoding the Strongylocentrotus
purpuratus neuropeptide-S/crustacean cardioactive
peptide-type receptor
Using total cDNA from 72 h embryonic S. purpuratus as a tem-
plate, the full-length cDNA of the S. purpuratus NPS/CCAP-
type receptor, including 50 and 30 untranslated regions (UTR),
was amplified by PCR using Phusion high-fidelity PCR
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TAG-30 and 50-GTCAGATCAGATATAGCAGT-30. The PCR
product was gel-extracted and purified using a QIAquick gel
extraction kit (QIAgen) before being blunt-end cloned into a
pBluescript SKII (þ) vector (Agilent Technologies) cut with a
EcoRV-HF restriction endonuclease (NEB). Subsequently, the
full-length cDNA of the S. purpuratus NPS/CCAP-type recep-
tor was subcloned into the eukaryotic expression vector
pcDNA 3.1þ (Invitrogen) cut with BamHI and ApaI restriction
endonucleases (NEB) using the oligos 50-cgggatccCACCATGG
CGACACAAGTGA-30 and 50-atcgggcccCTACATCGGACTAG
TAGTC-30. The partial Kozak sequence (CACC) was incorpor-
ated immediately preceding the authentic initiation codon to
optimize initiation of translation. The clone was then sequenced
(Eurofins Genomics) from the T7 and pCR3.1-BGH-rev sequen-
cing primer sites.
3.3. Pharmacological characterization of heterologously
expressed Strongylocentrotus purpuratus neuropeptide-
S/crustacean cardioactive peptide-type receptor
NGFFFamide and other synthetic NG peptides (NGFFYamide
and NGIWYamide) were assessed as ligands for the S. purpura-
tus NPS/CCAP-type receptor using an in vitro calcium (Ca2þ)
mobilization assay that has been employed previously for deor-
phanization of invertebrate neuropeptide receptors [20,21].
Chinese hamster ovary (CHO)-K1 cells stably overexpressing
the mitochondrial targeted apo-aequorin and the human Ga16
protein were used as a heterologous expression system. The
cells were cultivated in Dulbecco’s modified Eagle’s medium/
F-12 Ham (Sigma-Aldrich) supplemented with 10% fetal
bovine serum (Sigma-Aldrich), 100 UI ml21 of penicillin/strep-
tomycin (Invitrogen), 250 mg ml21 zeocin (Invitrogen) and
2.5 mg ml21 amphotericin B (Sigma-Aldrich), in a humidified
atmosphere of 5% CO2 in air at 378C. Cells were transiently
transfected with the S. purpuratus NPS/CCAP-type receptor/
pcDNA 3.1þ construct using lipofectamine Ltx with plus
reagent (Invitrogen) according to the manufacturer’s instruc-
tions, whereas cells for negative control experiments were
transfected with an empty pcDNA 3.1þ eukaryotic expression
vector (Invitrogen). Two days post-transfection, cells were
challenged with NG peptides (within the concentration
range 10217 to 2.5  1024 M), and receptor activation at
each peptide concentration was monitored by measuring
Ca2þ levels for 30 s using a Mithras LB 940 luminometer
(Berthold Technologies). Ca2þ responses were normalized
to the total Ca2þ response monitored after addition of
Triton X-100 (0.1%), and measured in triplicate in at least
two independent experiments. Dose–response data were
determined as relative (%) to the highest value (100% acti-
vation). Half-maximal effective concentration (EC50) values
were calculated from dose–response curves, constructed
with a computerized nonlinear regression analysis using a
sigmoidal dose–response equation (SIGMAPLOT v. 12.0).
3.4. Identification of NG peptide precursors and
neuropeptide-S/crustacean cardioactive peptide-
type receptors in echinoderms
In addition to the NGFFFamide precursor in S. purpuratus
(class Echinoidea), precursors of NG peptides have alsobeen identified in other echinoderms. These include the pre-
cursor of NGIWYamide in the sea cucumber Apostichopus
japonicus (class Holothuroidea) [22] and the precursor of
NGFFYamide in the starfish Asterias rubens (class Asteroidea)
[23]. Here, we sought to identify candidate NPS/CCAP-type
receptors for these peptides. We also sought to identify pre-
cursors of NG peptides and NPS/CCAP-type receptors in
species belonging to the two other extant echinoderm classes:
class Ophiuroidea (the brittle star Ophionotus victoriae) and
class Crinoidea (the feather star Antedon mediterranea). Tran-
scriptome sequence data from A. japonicus [24], A. rubens
[23], O. victoriae [25] and A. mediterranea [25] were subject
to BLAST analysis using SEQUENCESERVER (http://www.
sequenceserver.com), with the S. purpuratus NGFFFamide
precursor and S. purpuratus NPS/CCAP-type receptor
employed as protein query sequences.4. Results
4.1. Mass spectrometric detection of NGFFFamide
in extracts of the sea urchin Strongylocentrotus
purpuratus
To test the hypothesis that NPS/CCAP-type receptors in
deuterostomian invertebrates are activated by NG peptides,
the S. purpuratus NPS/CCAP-type receptor was selected as
a model system. Therefore, we first had to establish that its
putative ligand, NGFFFamide, is present in S. purpuratus.
Indirect evidence that NGFFFamide is derived from the NG
peptide-type precursor in sea urchins has been provided by
the discovery that synthetic NGFFFamide is a potent stimu-
lator of muscle contraction in the sea urchin Echinus
esculentus [26]. However, definitive proof that NGFFFamide
exists in S. purpuratus required use of mass spectrometry.
A peptide with the expected molecular mass for protonated
NGFFFamide (630.3) was detected in extracts of S. purpuratus
and its chromatographic properties were identical to syn-
thetic NGFFFamide (electronic supplementary material,
figure S1). These data confirmed that NGFFFamide is a
naturally occurring peptide in S. purpuratus.4.2. Cloning and sequencing of a cDNA encoding the
Strongylocentrotus purpuratus neuropeptide-
S/crustacean cardioactive peptide-type receptor
The occurrence of a gene in S. purpuratus encoding an NPS/
CCAP-type receptor has been reported previously [8,27,28],
and transcriptome sequencing [29] has confirmed the
sequence of a predicted 444-residue protein. To enable
pharmacological characterization of this receptor, a cDNA
encoding the receptor was cloned and sequenced using
total cDNA from 72 h old S. purpuratus embryos. Several
polymorphisms at the nucleotide level were identified, but
the sequence of the predicted 444-residue protein was identi-
cal to previous reports based on genomic/transcriptomic
sequence data (electronic supplementary material, figure S2;
GenBank accession number: KP171538).
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Figure 1. NG peptides are ligands for the S. purpuratus NPS/CCAP-type
receptor. Dose– response curves for Ca2þ responses evoked by the NG pep-
tides NGFFFamide (S. purpuratus), NGFFYamide (A. rubens) and NGIWYamide
(A. japonicus) in CHO-K1 cells expressing the S. purpuratus NPS/CCAP-type
receptor. Each point (+s.e.m.) represents mean values from at least two
independent experiments performed in at least triplicate. Dose– response
data are shown as relative (%) to the highest value (100% activation)
after normalization to the maximum Ca2þ response. The log EC50 values
(+s.e.m.) are NGFFFamide: 29.38+ 0.09; NGFFYamide: 28.25+ 0.04;
NGIWYamide: 26.44+ 0.04.
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Strongylocentrotus purpuratus neuropeptide-S/
crustacean cardioactive peptide-type receptor
To determine whether NGFFFamide is the cognate ligand for
the S. purpuratus NPS/CCAP-type receptor, the receptor was
expressed in CHO-K1 cells stably overexpressing the human
Ga16 protein and mitochondrially targeted apo-aequorin to
assay Ca2þ levels. Control experiments on cells transfected
with an empty vector revealed no effect of NGFFFamide on
Ca2þ levels (data not shown). However, in cells trans-
fected with the S. purpuratus NPS/CCAP-type receptor,
NGFFFamide caused dose-dependent Ca2þ elevation, with
an EC50 of 0.4 nM (figure 1). To characterize the structure–
activity relationships of NGFFFamide as a ligand for the
S. purpuratus NPS/CCAP-type receptor, two structurally
related NG peptides were tested: NGFFYamide from
A. rubens [23] and NGIWYamide from A. japonicus [22,30].
Both peptides activated the receptor dose-dependently, but
with lower potency than NGFFFamide; the EC50 value for
NGFFYamide was 5.7 nM, and the EC50 value for NGIWYa-
mide was 367 nM (figure 1). Interestingly, the 10-fold
difference in the potency of NGFFFamide and NGFFYamide
can be attributed to the occurrence of a single hydroxyl group
in the C-terminal tyrosine of NGFFYamide. The additional
10-fold reduction in potency seen with NGIWYamide can
be attributed to the more substantive differences in the
side-chain structures of the isoleucine–tryptophan dipeptide
in NGIWYamide and the phenylalanine–phenylalanine
dipeptide in NGFFYamide.4.4. Gene encoding the NGFFFamide receptor is located
adjacent to a gene encoding a vasopressin/
oxytocin-type receptor in the genome of
Strongylocentrotus purpuratus
Having demonstrated that NGFFFamide activates the
S. purpuratus NPS/CCAP-type receptor, we observed that
the gene encoding this receptor is located adjacent to a
gene encoding a VP/OT-type receptor in the S. purpuratus
genome (scaffold 114 [27]; electronic supplementary material,
figure S3). Furthermore, analysis of the phylogenetic distri-
bution of NPS/CCAP-type receptors and VP/OT-type
receptors indicates that the gene duplication event that gave
rise to these paralogous receptor types occurred in a
common ancestor of the Bilateria [8]. However, in other bila-
terian species for which genome sequence data are available,
including other deuterostomian invertebrates (e.g. B. floridae),
the genes encoding NPS/CCAP-type receptors, and VP/OT-
type receptors do not occupy adjacent positions (our unpub-
lished data, 2015). Therefore, the adjacent location of the
genes encoding these two receptor types in the genome of
S. purpuratus is remarkable because it presumably reflects
conservation of the adjacent positioning of genes generated
by a tandem gene duplication event that occurred approxi-
mately 600 million years ago in a common ancestor of
the Bilateria.4.5. Discovery of novel neuropeptide-S/crustacean
cardioactive peptide-type receptors and candidate
ligands derived from NG peptide-type precursors in
deuterostomian invertebrates
Having demonstrated that NGFFFamide is a cognate ligand for
the NPS/CCAP-type receptor of the sea urchin S. purpuratus
(phylum Echinodermata), we then sought to identify
genes/transcripts encoding NG peptide-type precursors and
NPS/CCAP-type receptors in other deuterostomian invert-
ebrates. This was of interest to facilitate reconstruction of
the evolution of NG peptide signalling systems in the
deuterostomian branch of the animal kingdom and to predict
the molecular identity of the ligands of NPS/CCAP-type
receptors in deuterostomian invertebrates.
Previous studies have reported the co-occurrence of genes
encoding NG peptide precursors and genes encoding NPS/
CCAP-type receptors in species belonging to other deuterosto-
mian phyla/subphyla—the acorn worm S. kowalevskii
(phylum Hemichordata) and the lancelet B. floridae (phylum
Chordata; subphylum Cephalochordata) [8,28]. Interestingly,
in the sea squirt Ciona intestinalis (phylum Chordata; subphy-
lum Urochordata), an NPS/CCAP-type receptor gene is not
present, and in accordance with this finding a gene encoding
an NG peptide-type precursor has also not been found in
this species [8,28]. Consistent with this finding, our analysis
of genome sequence data from another urochordate species,
the pelagic tunicate Oikopleura dioica [31] (http://www.geno-
scope.cns.fr/externe/GenomeBrowser/Oikopleura/), reveals
an absence of genes encoding an NPS/CCAP-type receptor
and an NG peptide-type precursor. Thus, it appears that loss
of a gene encoding an NPS/CCAP-type receptor is associated
with loss of an NGpeptide-type precursor gene or vice versa, a
finding that is consistent with our discovery that NGFFFamide
is the ligand of the NPS/CCAP-type receptor in the sea urchin
S. purpuratus.
(b) receptors
(a) precursors
A. jap (Echinodermata) 
A. rub (Echinodermata) 
S. pur (Echinodermata) 
S. kow (Hemichordata) 
B. flo (Chordata) 
H. sap (Chordata) 
O. vic (Echinodermata) 
H. sap NPSR 
B. flo NPSLR1 
B. flo NPSLR2 
S. kow NPSLR 
S. pur NGFFFa-R 
A. jap NPSLR 
A. rub NPSLR 
0.05 
A. med NPSLR 
1000 
874 
625 
879 
934 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - O. vic NPSLR? 
(c) neuropeptides
Figure 2. The NG peptide/NPS signalling system in deuterostomes. (a) Phylogenetic diagram comparing the structural organization of neuropeptide-S (NPS) and NG
peptide precursors in deuterostomes. Signal peptides are shown in blue, neuropeptides are shown in red (bounded by dibasic cleavage sites in green), and neu-
rophysin domains are shown in purple. (b) Neighbour-joining tree (including bootstrap values out of 1000) showing NPS-type receptors in deuterostomes, with the
hypothetical phylogenetic position of an as yet unidentified NPS-type receptor in the brittle star O. victoriae represented by the dashed line. (c) Alignment of
neuropeptide(s) derived from the NPS/NG peptide precursors shown in (a); these neuropeptides are proven (underlined) or candidate (not underlined) ligands
for the corresponding receptors shown in (b). The conserved NG motif is highlighted in yellow and the numbers in parentheses represent the number of
copies of the peptide in the precursor. H. sap, Homo sapiens; B. flo, Branchiostoma floridae; S. kow, Saccoglossus kowalevskii; S. pur, Strongylocentrotus purpuratus;
A. jap, Apostichopus japonicus; A. rub, Asterias rubens; O. vic, Ophionotus victoriae; A. med, Antedon mediterranea.
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CCAP-type receptors and NG peptide-type precursors in the
phylum Echinodermata beyond the sea urchin S. purpuratus
(class Echinoidea) by analysing transcriptome sequence data
obtained from representative species belonging to the four
other extant classes of this phylum: the Holothuroidea (the sea
cucumber A. japonicus), the Asteroidea (the starfish A. rubens),
the Ophiuroidea (the brittle star O. victoriae) and the Crinoidea
(the feather star A. mediterranea).
The Holothuroidea are a sister class to the Echinoidea in a
clade of echinoderms known as the Echinozoa [32,33]. In the
sea cucumber A. japonicus, a transcript encoding an NG
peptide-type precursor protein comprising five copies of the
neuropeptide NGIWYamide has been identified, but,
interestingly, unlike the sea urchin NGFFFamide precursor, it
lacks a C-terminal neurophysin domain [22,23] (figure 2a).
Here, our BLAST analysis of A. japonicus transcriptome
sequence data using the S. purpuratus NGFFFamide receptor
sequence as a query has identified a candidate NPS/CCAP-
type receptor for NGIWYamide (figure 2b; electronic
supplementary material, figure S4).
The Asteroidea (starfish) and Ophiuroidea (brittle stars)
are sister classes in the asterozoan clade of the phylum Echi-
nodermata [32,33]. Previously, we have reported discovery ofan NG-peptide-type precursor in the starfish A. rubens that is
very similar to the sea urchin NGFFFamide precursor—it
comprises two copies of the peptide NGFFYamide and a
C-terminal neurophysin domain [23]. Here, we have ident-
ified a transcript encoding an NPS/CCAP-type receptor in
A. rubens, which is a candidate receptor for the neuropeptide
NGFFYamide (figure 2b; electronic supplementary material,
figure S5; GenBank accession number: KP171535). Hitherto,
NG peptide-type precursors have not been identified in
species belonging to the class Ophiuroidea, but here we
have identified a transcript encoding an NG peptide-type
precursor in the brittle star species O. victoriae (figure 2a; elec-
tronic supplementary material, figure S6; GenBank accession
number: KP171536). The precursor is similar to the sea urchin
NGFFFamide precursor and the starfish NGFFYamide pre-
cursor—it has a C-terminal neurophysin domain and two
NG peptides. Interestingly, one of the NG peptides is
NGFFFamide (as found in S. purpuratus), and the other NG
peptide is NGFFYamide (as found in A. rubens; figure 2c).
However, analysis of our O. victoriae transcriptome sequence
data did not reveal a candidate NPS/CCAP-type receptor for
these peptides.
Basal to the Echinozoa and the Asterozoa in the phylum
Echinodermata is the class Crinoidea, which includes sea lilies
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data from the feather star A. mediterranea identified an NPS/
CCAP-type receptor in this species that is an orthologue
of the S. purpuratusNGFFFamide receptor (figure 2b; electronic
supplementarymaterial, figure S7; GenBank accession number:
KP171537). However, we were unable to identify a candidate
NG peptide-type ligand for this receptor in A. mediterranea.
Thus, when the A. mediterranea transcriptome sequence data
were subject to BLAST analysis using the NGFFFamide precur-
sor as a query, the only transcript that exhibited significant
similarity to the NGFFFamide precursor was a VP/OT-type
precursor (data not shown). Recognizing that there may have
been loss of the C-terminal neurophysin domain in the putative
A. mediterraneaNG peptide precursor, as previously seen in the
holothurian A. japonicus, we also searched for transcripts
encoding proteins comprising peptide sequences with an
NG peptide motif, but no candidate NG peptide precursors
were identified.5. Discussion
We have demonstrated that an orthologue of vertebrate
NPS-type receptors in the sea urchin S. purpuratus is activated
by NGFFFamide, a neuropeptide that is derived from a
neurophysin-containing precursor protein. This finding unites
a bilaterian family of neuropeptides that includes NPS-type
peptides in vertebrates, NG peptides in deuterostomian invert-
ebrates and CCAP-type neuropeptides in protostomian
invertebrates. Furthermore, it provides definitive support for
a scenario of neuropeptide-receptor evolution that has been
postulated based on phylogenetic reconstruction of bilaterian
neuropeptide systems [8,28]. Thus, our experimental demon-
stration of the NG peptide–NPS/CCAP-type receptor
signalling system provides the missing link that enables an
understanding of the relationship of NPS with CCAP and
their shared ancestry with VP/OT-type neuropeptides. The
sea urchin NGFFFamide receptor is the first neuropeptide
receptor to be characterized in an echinoderm, and our findings
illustrate the importance of studies on echinoderms (and other
deuterostomian invertebrates) in enabling reconstruction of the
evolutionary history of neural signalling systems.
In figure 3, we present a diagrammatic representation of
the evolutionary steps that gave rise, on the one hand, to
NPS in humans and other vertebrates, and on the other hand,
to the structurally unrelated neuropeptide CCAP in insects
(e.g.Drosophila andTribolium castaneum) andother protostomian
invertebrates. Our findings support a scenario wherein dupli-
cation of a gene encoding a VP/OT-type precursor occurred in
a common ancestor of the Bilateria (see x2 in figure 3a).
One copy retained the presumed ancestral features of the
precursor, which can be seen in the highly conserved struc-
ture of VP/OT-type precursors in extant Bilateria—an
N-terminal signal peptide, followed by a single copy of a
VP/OT-type peptide and a much larger neurophysin
domain. Thus, as illustrated in figure 3a, VP/OT-type precur-
sors that share this conserved structural organization have
been identified in species from many bilaterian phyla,
although loss of VP/OT-type precursors has occurred in
some lineages (e.g. Drosophila and other dipterans [34,42]).
The other gene copy diverged from the ancestral form,
but divergence took different courses in the protostomian
and the deuterostomian branches of the animal kingdom.In the protostomian lineage, the occurrence of a disulfide
bridge in the neuropeptide product(s) of the precursor was
retained, and in this respect, CCAP-type peptides in extant
protostomian species are similar to VP/OT-type peptides
(see asterisks in figure 3a). However, CCAP-type precursors
do not have a C-terminal neurophysin domain, and therefore
this feature of VP/OT-type precursors was lost during the
evolutionary history of CCAP-type precursor genes. In the
deuterostomian lineage, we see the opposite scenario. Thus,
here, the neuropeptides lost a disulfide bridge, but the neuro-
physin domain was retained, and these features can be seen,
for example, in the precursor of the neuropeptideNGFFFamide
in the sea urchin S. purpuratus. Interestingly, however, the
neurophysin domain was subsequently lost in the vertebrate
lineage that gave rise to the NPS-type precursors in extant
tetrapod vertebrates. Furthermore, the absence of NPS-
type precursors in teleosts and basal vertebrate classes
(Chondrichthyes, Agnatha) [6] indicates that there has also
been independent loss of NG peptide/NPS-type precursor
genes in multiple vertebrate lineages. However, the loss of
NG peptide/NPS-type precursor genes is not unique to basal
vertebrates; it is also a feature of urochordates. Furthermore,
in some invertebrate deuterostome lineages, such as the
holothurian echinoderms (sea cucumbers), NGpeptide precur-
sors have secondarily lost the neurophysin domain (see A. jap.
in figure 2a). Lastly, additional evidence of the occurrence of an
ancient gene duplication that gave rise to VP/OT-type precur-
sors and NPS/NG peptide/CCAP-type precursors can be
found in the genomes of extant animal species. Thus, in the
cephalochordate B. floridae, the gene encoding a VP/OT-type
precursor in this species is located in tandem with the gene
that encodes the precursor of the putativeNPS-likeNGpeptide
in this species—SFRNGVamide [8,23].
A contentious issue concerns the structural organization
of the ancestral precursor protein that gave rise to VP/
OT-type precursors and NPS/NG peptide/CCAP-type
precursors. In previously reported models of the evolution
of these two neuropeptide families, it was proposed that
the ancestral precursor would have comprised two neuro-
peptides—one copy of a VP/OT-type peptide and one copy
of an NPS/NG peptide/CCAP-type peptide, together with
a C-terminal neurophysin domain [8,28]. In our model
(figure 3a), the ancestral precursor comprises only one neuro-
peptide, and we speculate that this would have been similar
to VP/OT-type peptides and CCAP-type peptides in extant
animals in having two cysteine residues that form a disulfide
bridge. A key basis for this supposition is that the existence
of one VP/OT-type neuropeptide and one neurophysin
domain is a highly conserved feature of VP/OT-type neuro-
peptide precursors in extant Bilateria, and it seems likely,
therefore, that this reflects conservation of an ancestral
precursor structure. Furthermore, a biochemical basis for
this 1 : 1 relationship can be seen in the stoichiometry of the
interaction of VP/OT-type peptides with neurophysin,
where a homodimeric neurophysin complex binds two VP/
OT-type peptide molecules [18,43]. In the highly divergent
NPS/NG peptide/CCAP-type neuropeptide precursors,
there has been loss of the neurophysin domain in multiple
lineages, andwhere the neurophysin domain has been retained
it is in association with two to six copies of an NG peptide. The
significance of the retention of the neurophysin domain in
some, but not all NGpeptide-type precursors in deuterostomes
is unclear, but it is a fascinating issue for further investigation.
(a) evolution of precursors
(b) evolution of receptors (c) neuropeptides
x2
x2
n = 2
H. sap NPSR(1)
B. flo NPSLR
S. kow NPSLR
S. pur NGFFFa-R(2)
C. tel CCAPLR
L. gig CCAPLR
T. cas CCAPR(3)
H. sap VPR(4)
H. sap OTR(5)
B. flo VP/OTLR
S. kow VP/OTLR
S. pur VP/OTLR
C. tel VP/OTLR
L. sta VP/OTR(6)
T. cas VP/OTR(7)
C. ele VP/OTR(8)
n = 2
n = 4
n = 2
n = 3
n = 2
n = 2
neuropeptide-S precursor
NG peptide
precursors
deuterostomes
deuterostomes
deuterostomes
deuterostomes
protostomes
protostomes
protostomes
protostomes
CCAP-type
precursors
vasopressin precursor
vasopressin/oxytocin-
type precursors
oxytocin precursor
H. sap
H. sap
H. sap
B. flo
B. flo
S. kow
S. kow
S. pur
S. pur
C. tel
C. ele
C. tel
L. sta
L. gig
T. cas
T. cas
* *
*
* * *
*
*
*
*
*
*
*
*
*
Figure 3. Evolution of NPS/NG peptide/CCAP-type and vasopressin/oxytocin-type signalling systems in the bilateria. (a) Schematic showing how duplication of a
vasopressin (VP)/oxytocin (OT)-type neuropeptide precursor in a common ancestor of the bilateria gave rise to the highly conserved precursors of VP/OT-type neuro-
peptides and the divergent precursors of NPS, NG peptides and CCAP-type peptides in extant bilaterians. Signal peptides are shown in blue, neuropeptides are
shown in red (with the presence of a disulfide bridge labelled with an asterisk), dibasic cleavage sites are shown in green and neurophysin domains are shown in
purple. (b) Schematic showing how duplication of a receptor in a common ancestor of the bilateria (white-filled receptor symbol) gave rise to NPS/NG peptide/
CCAP-type receptors and VP/OT-type receptors in deuterostomian and protostomian species. Receptors where the molecular identity of the cognate ligand has been
determined are shown as a black-filled receptor symbols and receptors where the molecular identity of the cognate ligand remains to be proven are shown as
grey-filled receptor symbols. Where multiple isoforms of a receptor type occur in a species, this is shown as n ¼ x. (c) Alignment of NPS/NG peptide/CCAP-type
neuropeptides and VP/OT-type neuropeptides that are derived from the precursors shown in (a), which are proven or candidate ligands for the receptors shown in
(b). An NG motif, which is highlighted in yellow, is a conserved feature of NPS, NG peptides and some CCAP-type peptides. A pair of cysteine residues (underlined),
which form a disulfide bridge, are a conserved feature of CCAP-type peptides and VP/OT-type peptides. A TG motif and two phenylalanine (F) residues, which are
conserved in sub-sets of peptides, are shown in purple. H. sap, Homo sapiens; B. flo, Branchiostoma floridae; S. kow, Saccoglossus kowalevskii; S. pur, Strongylocen-
trotus purpuratus; C. tel, Capitella teleta; L. gig, Lottia gigantea; T. cas, Tribolium castaneum; L. sta, Lymnaea stagnalis; C. ele, Caenorhabditis elegans. References:
1. [3]; 2. this paper; 3. [34]; 4. [35–37]; 5. [38]; 6. [39]; 7. [40]; 8. [21,41].
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tionally important for the biosynthesis of NG peptides.
However, because the number of NG peptides in association
with neurophysin in NG peptide precursors is variable (2 : 1;
5 : 1; 6 : 1—figures 2a and 3a), it remains unclear whether or
not NG peptides actually bind to their associated neurophysin.
If they do, then what is the stoichiometry of the interaction?
If they do not, then what is the role of the neurophysin
domain in NG peptide precursors?
In order that duplication of a gene encoding an ancestral
VP/OT-type precursor could give rise to two functional pep-
tide-receptor signalling systems, there would have to havebeen a contemporaneous duplication of the gene encoding the
receptor for the putative ancestral VP/OT-type peptide. This
gene duplication is portrayed as x2 in the dendrogram shown
in figure 3b. As reported above for NG peptide precursor
genes, additional evidence of the occurrence of an ancient
gene duplication that gave rise to VP/OT-type receptors and
NPS/NG peptide/CCAP-type receptors can be found in the
genomes of extant animal species. Thus, in the sea urchin
S. purpuratus, the gene encoding a VP/OT-type precursor is
located in tandem with the gene encoding the NGFFFamide
receptor that we have characterized pharmacologically in this
study (electronic supplementary material, figure S3).
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 on November 1, 2015http://rsob.royalsocietypublishing.org/Downloaded from In figure 3c, we show sequence alignments of proven or
candidate peptide ligands for the receptors in figure 3b. By
comparing the sequences of NPS, NG peptides and CCAP-
type peptides with each other and with the sequences of
VP/OT-type peptides, a number of shared characteristics
can be seen, which may be reflective of the common evol-
utionary origins of these neuropeptides. Comparison of
CCAP-type peptides with VP/OT-type peptides highlights
a common feature of two cysteine residues, which in the
mature bioactive peptides form a disulfide bridge, as high-
lighted above. Interestingly, comparison within the NPS/NG
peptide/CCAP group reveals that the NG motif is not only a
feature of NPS and NG peptides in deuterostomes, as it is
also a feature of CCAP-type neuropeptides in molluscs. This
is illustrated in figure 3c with a CCAP peptide from the
limpet Lottia gigantea, but the NG motif is also a feature of
CCAP-type peptides in other mollusc species (e.g. Conus
villepinii, GI:325529921; Aplysia californica, GI:524893759).
Thus, the NG motif may be a unifying characteristic of the
bilaterian family of neuropeptides that includes NPS, NG
peptides and CCAP-type peptides, but with subsequent loss
of the glycine residue or substitution of the glycine with
another residue (alanine) in some CCAP-type peptides.
A feature that appears to unify NPS with CCAP-type peptides
is a Thr–Gly (TG) motif, which is absent in NG peptides of
deuterostomian invertebrates (figure 3c). Lastly, alignment
of two phenylalanine residues in CCAP-type neuropeptides
with phenylalanines in NPS and NG peptides reveals what
appear to be differential patterns of conservation in chordate
and non-chordate deuterostomes. Thus, the phenylalanine
residue at position two in CCAPpeptides alignswith a phenyl-
alanine residue at position two in NPS and in the NPS-like
NG peptide of B. floridae, whereas the phenylalanine residue
at position five or six in CCAP peptides aligns with a phenyl-
alanine residue at position three in ambulacrarian NG
peptides (figure 3c).
Our discovery that the NPS/CCAP-type receptor in the
sea urchin S. purpuratus is activated by the NG peptide
NGFFFamide provides a basis for investigation of the physio-
logical roles of NG peptides in deuterostomian invertebrates.
This will provide new insights into the evolution of thephysiological and behavioural functions of NPS/NG pep-
tide/CCAP-type neuropeptides in the animal kingdom.
Based upon what is currently known, a common theme
seems to be a role in control of behaviours that are associated
with a heightened state of arousal. Thus, NPS causes anxioly-
sis and arousal in mammals [3], NG peptides trigger dynamic
behaviours linked to feeding or reproduction in echinoderms
[23,44], and CCAP activates the ecdysis motor programme in
arthropods that results in shedding of the exoskeleton [11].
As we learn more about the physiological/behavioural
roles of both NPS/NG peptide/CCAP-type neuropeptides
and VP/OT-type neuropeptides in a variety of phyla, it
may be possible to reconstruct how the highly conserved
VP/OT-type and the highly divergent NPS/NG peptide/
CCAP-type neuropeptide signalling systems acquired distinct
physiological roles following ancient gene duplication events
in the common ancestor of the Bilateria.
Data accessibility. Novel nucleotide sequence data have been deposited in
the GenBank database (accession numbers KP171535–KP171538). The
datasets supporting this article have been uploaded as part of the
electronic supplementary material. NG peptide precursor sequences,
the NGFFFamide receptor sequence and other putative NG peptide
receptor sequences have also been included in FASTA format in
electronic supplementary material, figures S8 and S9.
Acknowledgements. We are very grateful to Dr Liliane Schoofs (KU
Leuven) for her support in enabling pharmacological identification
of the NGFFFamide receptor and to Dr Robert Burke (University of
Victoria, Canada) for providing extracts of S. purpuratus. We are
grateful to Alan Scott (QMUL) for technical assistance with mass
spectrometry.
Funding statement. This work was supported by a PhD studentship
funded by QMUL and a Company of Biologists (Journal of Experimen-
tal Biology) Travelling Fellowship awarded to D.C.S. I.B. was
supported by a postdoctoral fellowship from the Research Foun-
dation Flanders and ERC grant no. ERC-2013-ADG-340318.
Authors’ contributions. Cloning and sequencing of NGFFFamide receptor
cDNA (D.C.S.); pharmacological characterization of NGFFFamide
receptor (D.C.S. and I.B.); NGFFFamide mass spectrometry
(M.L.R.); transcriptome sequencing, assembly and analysis (D.C.S.,
L.M.B., M.R.E.); S. purpuratus cDNA synthesis (P.O). M.R.E. and
D.C.S. conceived the study and wrote the first draft of the paper.
All authors contributed to the submitted final draft of the paper
and gave final approval for publication.
Conflict of interests. We have no competing interests.References1. Civelli O, Reinscheid RK, Zhang Y, Wang Z,
Fredriksson R, Schioth HB. 2013 G protein-coupled
receptor deorphanizations. Annu. Rev. Pharmacol.
Toxicol. 53, 127–146. (doi:10.1146/annurev-
pharmtox-010611-134548)
2. Gupte J, Cutler G, Chen JL, Tian H. 2004 Elucidation
of signaling properties of vasopressin receptor-
related receptor 1 by using the chimeric receptor
approach. Proc. Natl Acad. Sci. USA 101,
1508–1513. (doi:10.1073/pnas.0308250100)
3. Xu YL et al. 2004 Neuropeptide S: a neuropeptide
promoting arousal and anxiolytic-like effects.
Neuron 43, 487–497. (doi:10.1016/j.neuron.
2004.08.005)
4. Okamura N, Hashimoto K, Iyo M, Shimizu E,
Dempfle A, Friedel S, Reinscheid RK. 2007 Gender-
specific association of a functional codingpolymorphism in the Neuropeptide S receptor gene
with panic disorder but not with schizophrenia or
attention-deficit/hyperactivity disorder. Prog.
Neuropsychopharmacol. Biol. Psychiatry 31,
1444–1448. (doi:10.1016/j.pnpbp.2007.06.026)
5. Domschke K et al. 2011 Neuropeptide S receptor
gene: converging evidence for a role in panic
disorder. Mol. Psychiatry 16, 938–948. (doi:10.
1038/mp.2010.81)
6. Reinscheid RK. 2007 Phylogenetic appearance of
neuropeptide S precursor proteins in tetrapods.
Peptides 28, 830–837. (doi:10.1016/j.peptides.
2007.01.008)
7. Jekely G. 2013 Global view of the evolution and
diversity of metazoan neuropeptide signaling. Proc.
Natl Acad. Sci. USA 110, 8702–8707. (doi:10.1073/
pnas.1221833110)8. Mirabeau O, Joly JS. 2013 Molecular evolution of
peptidergic signaling systems in bilaterians. Proc.
Natl Acad. Sci. USA 110, E2028–E2037. (doi:10.
1073/pnas.1219956110)
9. Park Y, Kim YJ, Adams ME. 2002 Identification of G
protein-coupled receptors for Drosophila PRXamide
peptides, CCAP, corazonin, and AKH supports a theory
of ligand-receptor coevolution. Proc. Natl Acad. Sci. USA
99, 11 423–11 428. (doi:10.1073/pnas.162276199)
10. Belmont M, Cazzamali G, Williamson M, Hauser F,
Grimmelikhuijzen CJ. 2006 Identification of four
evolutionarily related G protein-coupled receptors
from the malaria mosquito Anopheles gambiae.
Biochem. Biophys. Res. Commun. 344, 160–165.
(doi:10.1016/j.bbrc.2006.03.117)
11. Park JH, Schroeder AJ, Helfrich-Forster C, Jackson FR,
Ewer J. 2003 Targeted ablation of CCAP
rsob.royalsocietypublishing.org
Open
Biol.5:150030
9
 on November 1, 2015http://rsob.royalsocietypublishing.org/Downloaded from neuropeptide-containing neurons of Drosophila
causes specific defects in execution and circadian
timing of ecdysis behavior. Development 130,
2645–2656. (doi:10.1242/dev.00503)
12. Stangier J, Hilbich C, Beyreuther K, Keller R. 1987
Unusual cardioactive peptide (CCAP) from
pericardial organs of the shore crab Carcinus
maenas. Proc. Natl Acad. Sci. USA 84, 575–579.
(doi:10.1073/pnas.84.2.575)
13. Loi PK, Emmal SA, Park Y, Tublitz NJ. 2001
Identification, sequence and expression of a
crustacean cardioactive peptide (CCAP) gene in the
moth Manduca sexta. J. Exp. Biol. 204, 2803–2816.
14. Turbeville JM, Schulz JR, Raff RA. 1994
Deuterostome phylogeny and the sister group of the
chordates: evidence from molecules and
morphology. Mol. Biol. Evol. 11, 648–655.
15. Pitti T, Manoj N. 2012 Molecular evolution of the
neuropeptide S receptor. PLoS ONE 7, e34046.
(doi:10.1371/journal.pone.0034046)
16. Elphick MR. 2010 NG peptides: a novel family of
neurophysin-associated neuropeptides. Gene 458,
20–26. (doi:10.1016/j.gene.2010.03.004)
17. Roth AL et al. 2006 Structure-activity studies on
neuropeptide S: identification of the amino acid
residues crucial for receptor activation. J. Biol.
Chem. 281, 20 809–20 816. (doi:10.1074/jbc.
M601846200)
18. De Bree FM. 2000 Trafficking of the vasopressin
and oxytocin prohormone through the regulated
secretory pathway. J. Neuroendocrinol. 12, 589–
594. (doi:10.1046/j.1365-2826.2000.00521.x)
19. Husson SJ, Clynen E, Baggerman G, De Loof A,
Schoofs L. 2005 Discovering neuropeptides in
Caenorhabditis elegans by two dimensional liquid
chromatography and mass spectrometry. Biochem.
Biophys. Res. Commun. 335, 76–86. (doi:10.1016/j.
bbrc.2005.07.044)
20. Janssen T, Meelkop E, Lindemans M, Verstraelen K,
Husson SJ, Temmerman L, Nachman RJ, Schoofs L.
2008 Discovery of a cholecystokinin-gastrin-like
signaling system in nematodes. Endocrinology 149,
2826–2839. (doi:10.1210/en.2007-1772)
21. Beets I, Janssen T, Meelkop E, Temmerman L,
Suetens N, Rademakers S, Jansen G, Schoofs L. 2012
Vasopressin/oxytocin-related signaling regulates
gustatory associative learning in C. elegans. Science
338, 543–545. (doi:10.1126/science.1226860)
22. Elphick MR. 2012 The protein precursors of peptides
that affect the mechanics of connective tissue
and/or muscle in the echinoderm Apostichopus
japonicus. PLoS ONE 7, e44492. (doi:10.1371/
journal.pone.0044492)23. Semmens DC, Dane RE, Pancholi MR, Slade SE,
Scrivens JH, Elphick MR. 2013 Discovery of a novel
neurophysin-associated neuropeptide that triggers
cardiac stomach contraction and retraction in
starfish. J. Exp. Biol. 216, 4047–4053. (doi:10.
1242/jeb.092171)
24. Du H et al. 2012 Transcriptome sequencing and
characterization for the sea cucumber Apostichopus
japonicus (Selenka, 1867). PLoS ONE 7, e33311.
(doi:10.1371/journal.pone.0033311)
25. Elphick MR, Semmens DC, Blowes LM, Levine J,
Lowe CJ, Arnone MI, Clark MS. 2015 Reconstructing
SALMFamide neuropeptide precursor evolution in
the phylum Echinodermata: ophiuroid and crinoid
sequence data provide new insights. Front.
Endocrinol. 6, 2. (doi:10.3389/fendo.2015.00002)
26. Elphick MR, Rowe ML. 2009 NGFFFamide and
echinotocin: structurally unrelated myoactive
neuropeptides derived from neurophysin-containing
precursors in sea urchins. J. Exp. Biol. 212,
1067–1077. (doi:10.1242/jeb.027599)
27. Sodergren E et al. 2006 The genome of the sea
urchin Strongylocentrotus purpuratus. Science 314,
941–952. (doi:10.1126/science.1133609)
28. Valsalan R, Manoj N. 2014 Evolutionary history of
the neuropeptide S receptor/neuropeptide S system.
Gen. Comp. Endocrinol. 209, 11–20. (doi:10.1016/j.
ygcen.2014.05.011)
29. Tu Q, Cameron RA, Worley KC, Gibbs RA, Davidson
EH. 2012 Gene structure in the sea urchin
Strongylocentrotus purpuratus based on
transcriptome analysis. Genome Res. 22,
2079–2087. (doi:10.1101/gr.139170.112)
30. Iwakoshi E, Ohtani M, Takahashi T, Muneoka Y,
Ikeda T, Fujita T, Minakata H, Nomoto K. 1995
Comparative aspects of structure and action of
bioactive peptides isolated from the sea cucumber
Stichopus japonicus. In Peptide chemistry 1994 (ed.
M Ohno), pp. 261–264. Osaka, Japan: Protein
Research Foundation.
31. Denoeud F et al. 2010 Plasticity of animal genome
architecture unmasked by rapid evolution of a
pelagic tunicate. Science 330, 1381–1385. (doi:10.
1126/science.1194167)
32. Telford MJ, Lowe CJ, Cameron CB, Ortega-Martinez
O, Aronowicz J, Oliveri P, Copley RR. 2014
Phylogenomic analysis of echinoderm class
relationships supports Asterozoa. Proc R. Soc. B 281,
20140479. (doi:10.1098/rspb.2014.0479)
33. O’Hara TD, Hugall AF, Thuy B, Moussalli A. 2014
Phylogenomic resolution of the class Ophiuroidea
unlocks a global microfossil record. Curr. Biol. 24,
1874–1879. (doi:10.1016/j.cub.2014.06.060)34. Stafflinger E, Hansen KK, Hauser F, Schneider M,
Cazzamali G, Williamson M, Grimmelikhuijzen CJ.
2008 Cloning and identification of an oxytocin/
vasopressin-like receptor and its ligand from insects.
Proc. Natl Acad. Sci. USA 105, 3262–3267. (doi:10.
1073/pnas.0710897105)
35. Birnbaumer M, Seibold A, Gilbert S, Ishido M,
Barberis C, Antaramian A, Brabet P, Rosenthal W.
1992 Molecular cloning of the receptor for human
antidiuretic hormone. Nature 357, 333–335.
(doi:10.1038/357333a0)
36. Sugimoto T, Saito M, Mochizuki S, Watanabe Y,
Hashimoto S, Kawashima H. 1994 Molecular cloning
and functional expression of a cDNA encoding the
human V1b vasopressin receptor. J. Biol. Chem.
269, 27 088–27 092.
37. Thibonnier M, Auzan C, Madhun Z, Wilkins P, Berti-
Mattera L, Clauser E. 1994 Molecular cloning,
sequencing, and functional expression of a cDNA
encoding the human V1a vasopressin receptor.
J. Biol. Chem. 269, 3304–3310.
38. Kimura T, Tanizawa O, Mori K, Brownstein MJ,
Okayama H. 1992 Structure and expression of a
human oxytocin receptor. Nature 356, 526–529.
(doi:10.1038/356526a0)
39. van Kesteren RE et al. 1995 A novel G protein-
coupled receptor mediating both vasopressin- and
oxytocin-like functions of Lys-conopressin in
Lymnaea stagnalis. Neuron 15, 897–908. (doi:10.
1016/0896-6273(95)90180-9)
40. Li B, Beeman RW, Park Y. 2011 Functions of
duplicated genes encoding CCAP receptors in the
red flour beetle, Tribolium castaneum. J. Insect
Physiol. 57, 1190–1197. (doi:10.1016/j.jinsphys.
2011.05.011)
41. Garrison JL, Macosko EZ, Bernstein S, Pokala N,
Albrecht DR, Bargmann CI. 2012 Oxytocin/
vasopressin-related peptides have an ancient role in
reproductive behavior. Science 338, 540–543.
(doi:10.1126/science.1226201)
42. Gruber CW. 2014 Physiology of invertebrate oxytocin
and vasopressin neuropeptides. Exp. Physiol. 99,
55–61. (doi:10.1113/expphysiol.2013.072561)
43. De Bree FM, Burbach JP. 1998 Structure– function
relationships of the vasopressin prohormone
domains. Cell Mol. Neurobiol. 18, 173–191. (doi:10.
1023/A:1022564803093)
44. Kato S, Tsurumaru S, Taga M, Yamane T, Shibata Y,
Ohno K, Fujiwara A, Yamano K, Yoshikuni M. 2009
Neuronal peptides induce oocyte maturation and
gamete spawning of sea cucumber, Apostichopus
japonicus. Dev. Biol. 326, 169–176. (doi:10.1016/j.
ydbio.2008.11.003)
